Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (215)	11/7/1998 11:56:00 PM
From: John Metcalf	Read Replies (1) \| Respond to of 1073

Peter, nice of you to mention the selection of VRTX in teens, and leave out the recommendation of PCOP, a couple days before the downgrade. If my crystal ball doesn't come back soon, I may run for Governor of Minnesota, which apparently can be done as a lark -:) With a 60% run in biotechs, the purpose of Bounce may be fulfilled. A trader should sell it out and wait for Bounce candidates to appear again. But then if you had MLNM @ $12, BCHE in the teens, SEPR in the $40's.... buying and holding would make great sense. However acquired, there are two different management strategies here.